UNIWERSYTET MEDYCZNY W LUBLINIE

Their core work

Uniwersytet Medyczny w Lublinie is a Polish medical university that brings clinical and public health research expertise to European consortia. Their H2020 work spans two distinct but complementary domains: assistive robotics for patients with mild cognitive impairment (MCI) and the systematic appraisal of child and adolescent primary health care models across Europe. In both cases, they contributed as a clinical knowledge partner — providing medical expertise, patient population access, and healthcare system context that purely technical or policy partners cannot supply. They are positioned at the intersection of clinical medicine and health services research.

What they specialise in

How they've shifted over time

Both H2020 projects ran concurrently from 2015 to 2018, so there is no genuine temporal shift to analyse — the apparent keyword gap between "early" and "recent" periods reflects data coverage differences between projects rather than a real evolution in focus. RAMCIP left no keyword record in the dataset, while MOCHA was richly tagged with child health and primary care terms. What can be said is that within this single cohort, the university demonstrated breadth across two areas — assistive technology for aging patients and paediatric health systems — rather than deep specialisation in one lane.

With only two concurrent projects and no H2020 activity beyond 2018, the direction is unclear; a consortium builder should verify whether this university has continued in Horizon Europe and in which domain.

How they like to work

This university has exclusively participated as a consortium partner — never as coordinator — across both projects. Despite only two projects, they engaged with 26 distinct partners in 16 countries, which is a high network density for a small portfolio and suggests they joined well-connected, large multi-partner consortia rather than small bilateral collaborations. This pattern indicates they are comfortable operating inside complex international consortia but have not yet taken on project leadership responsibility.

The university reached 26 unique partners across 16 countries from just two projects, reflecting participation in broad pan-European consortia. No geographic clustering is visible from the available data, suggesting partners were selected by topic rather than by regional proximity.

What sets them apart

This is one of the few Polish medical universities with H2020 experience in both assistive robotics (RAMCIP) and comparative child health systems (MOCHA) — an unusual pairing that signals genuine interdisciplinary openness. For a consortium needing a Central/Eastern European clinical validation site with experience in both ageing and paediatric populations, this university offers a geographic and demographic perspective often absent from Western-dominated health consortia. Their relatively modest funding footprint also suggests they can integrate as a focused clinical partner without dominating project budgets.

Highlights from their portfolio

• RAMCIP
  The largest of their two projects (EUR 364,062), involving a robotic assistant for MCI patients at home — an unusual role for a medical university, indicating willingness to engage in technology-clinical boundary research.
• MOCHA
  A pan-European appraisal of child health care models, producing one of the richest keyword profiles in the dataset — covering primary care, school health, adolescent services, and health economics — which points to genuine policy-facing research capacity.